These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31284404)

  • 21. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States.
    Garg A; Papagermanos V; Midura M; Strunk A; Merson J
    J Am Acad Dermatol; 2018 Sep; 79(3):495-500.e1. PubMed ID: 29499293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the Demographic Predictors and Associated Comorbidities in Children Hospitalized with Conduct Disorder.
    Patel RS; Amaravadi N; Bhullar H; Lekireddy J; Win H
    Behav Sci (Basel); 2018 Sep; 8(9):. PubMed ID: 30181470
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimensional and Categorical Correlates of Substance Use Disorders among Canadian Adolescents with Bipolar Disorder.
    Scavone A; Timmins V; Collins J; Swampillai B; Fonseka TM; Newton D; Naiberg M; Mitchell R; Ko A; Shapiro J; Collinger K; Boulos C; Goldstein BI
    J Can Acad Child Adolesc Psychiatry; 2018 Aug; 27(3):159-166. PubMed ID: 30038653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do cannabis use disorders increase medication non-compliance in schizophrenia?: United States Nationwide inpatient cross-sectional study.
    Patel RS; Sreeram V; Vadukapuram R; Baweja R
    Schizophr Res; 2020 Oct; 224():40-44. PubMed ID: 33183946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Total population-based study of the impact of substance use disorders on the overall survival of psychiatric inpatients.
    Steingrímsson S; Sigurdsson MI; Aspelund T; Sigfússon S; Magnússon A
    Nord J Psychiatry; 2016; 70(3):161-6. PubMed ID: 26317284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance Use Disorders in Elderly Admissions to an Academic Psychiatric Inpatient Service over a 10-Year Period.
    Dombrowski D; Norrell N; Holroyd S
    J Addict; 2016; 2016():4973018. PubMed ID: 27840765
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabis Use Is an Independent Predictor for Acute Myocardial Infarction Related Hospitalization in Younger Population.
    Patel RS; Manocha P; Patel J; Patel R; Tankersley WE
    J Adolesc Health; 2020 Jan; 66(1):79-85. PubMed ID: 31611137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
    Kazour F; Awaida C; Souaiby L; Richa S
    Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbid Cannabis and Tobacco Use Disorders in Hospitalized Patients with Psychotic-Spectrum Disorders.
    Reeves LE; Gaudiano BA; Metrik J; Guzman Holst C; Morena A; Sydnor VJ; Weinstock LM; Epstein-Lubow G
    J Dual Diagn; 2018; 14(3):171-180. PubMed ID: 30265850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive Profiles of Adolescent Inpatients with Substance Use Disorder.
    Becker ABC; Lüken LM; Kelker L; Holtmann M; Daseking M; Legenbauer T
    Children (Basel); 2022 May; 9(5):. PubMed ID: 35626933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of alcohol combined with other substance use disorders in an American Indian community sample.
    Gilder DA; Stouffer GM; Lau P; Ehlers CL
    Drug Alcohol Depend; 2016 Apr; 161():222-9. PubMed ID: 26896167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Region-Wise Distribution of Schizophrenia With Cannabis Abuse and Medication Non-Compliance in the United States: A Nationwide Analysis of 51,975 Hospitalizations.
    Vadukapuram R; Zahid S; Lee HK; Patel RS
    Cureus; 2020 May; 12(5):e7936. PubMed ID: 32494541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct Disorder.
    Wilens TE; Biederman J; Martelon M; Zulauf C; Anderson JP; Carrellas NW; Yule A; Wozniak J; Fried R; Faraone SV
    J Clin Psychiatry; 2016 Oct; 77(10):1420-1427. PubMed ID: 27574842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders.
    Coviello DM; Lovato R; Apostol K; Eisenberg MM; Metzger DS; Szucs-Reed R; Kiryankova-Dalseth N; Kelly D; Jackson A; Plano M; Blank MB
    Community Ment Health J; 2018 Nov; 54(8):1146-1153. PubMed ID: 29752639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.